# A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

> **NCT02652650** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ethinylestradiol
- **DRUG:** Norethindrone
- **DRUG:** JNJ-63623872

## Key facts

- **NCT ID:** NCT02652650
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652650, "A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02652650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*